References
- 1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses; Gorbalenya AE, Baker SC. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. 2020;5(4): 536–544.10.1038/s41564-020-0695-z
- 2. WHO Director-General’s opening remarks at the media briefing on COVID-19: 11 March 2020. Published March 11, 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19---11-march-2020 [Accessed 26th December 2020].
- 3. World Health Organization. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed on 26 December 2020].
- 4. Ordinul nr. 1.418 din 7 august 2020 privind modificarea anexei la Ordinul Ministrului Sănătății, nr. 487/2020 pentru aprobarea protocolului de tratament al infecției cu virusul SARS-Cov-2. In: Monitorul Oficial al României. Partea I, nr. 242 din 24 martie 2020, Available from: http://legislatie.just.ro/Public/DetaliiDocument/229019 [Accessed 26th December 2020].
- 5. Slavcovici A, Streinu-Cercel A, Ţăţulescu D, Radulescu A, Mera S, Marcu C, et al. The role of risk factors ‘carmeli score’ and infective endocarditis classification in the assessment of appropriate empirical therapy. Therapeutics, Pharmacology and Clinical Toxicology. 2009;13(1): 52–56.
- 6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13): 1239–1242.10.1001/jama.2020.2648
- 7. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16): 1574–1581.10.1001/jama.2020.5394
- 8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229): 1054–1062.10.1016/S0140-6736(20)30566-3
- 9. Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 2021;27(1): 83–88.10.1016/j.cmi.2020.07.041
- 10. Xing Q, Li GJ, Xing YH, Chen T, Li WJ, Ni W, et al. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. medRxiv.
- 11. Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia’an; Yu, Ting; Zhang, Xinxin; Zhang, Li (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, S0140673620302117–. https://doi.org/10.1016/S0140-6736(20)30211-710.1016/S0140-6736(20)30211-7
- 12. Yiqi Fu, Qing Yang, Min Xu, Haishen Kong, Hongchao Chen, Yajie Fu, Yake Yao, Hua Zhou, Jianying Zhou, Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019, Open Forum Infectious Diseases, Volume 7, Issue 6, June 2020, ofaa220, https://doi.org/10.1093/ofid/ofaa22010.1093/ofid/ofaa220731376232613024
- 13. Bassetti, M., Kollef, M.H. & Timsit, JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med 46, 2071–2074 (2020). https://doi.org/10.1007/s00134-020-06219-810.1007/s00134-020-06219-8747999832902729